Sernova Biotherapeutics Inc SEOVF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 45.10K | 773.70K | 424.80K | 189.10K | 60.40K |
| Total Receivables | 7.80K | 85.80K | 92.60K | 87.50K | 192.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 210.50K | 261.00K | 54.50K | 96.30K | 108.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 263.40K | 1.12M | 571.90K | 373.00K | 361.10K |
|
|
|||||
| Total Current Assets | 263.40K | 1.12M | 571.90K | 373.00K | 361.10K |
| Net Property, Plant & Equipment | 3.20K | 6.50K | 9.80K | 12.60K | 135.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 165.00K | 159.70K | 161.80K |
| Total Assets | 266.60K | 1.13M | 746.70K | 545.30K | 658.10K |
|
|
|||||
| Total Accounts Payable | 3.64M | 3.69M | 13.29M | 12.61M | 14.22M |
| Total Accrued Expenses | 3.16M | 2.71M | 2.69M | 2.43M | 704.60K |
| Short-term Debt | -- | -- | 2.85M | 2.66M | 2.64M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.79M | 1.63M | -- | -- | 45.70K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.59M | 8.04M | 18.83M | 17.70M | 17.61M |
|
|
|||||
| Total Current Liabilities | 8.59M | 8.04M | 18.83M | 17.70M | 17.61M |
| Long-Term Debt | 56.30K | 168.40K | 795.80K | 744.60K | 681.50K |
| Short-term Debt | -- | -- | 2.85M | 2.66M | 2.64M |
| Capital Leases | -- | -- | -- | -- | 23.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.65M | 8.21M | 19.62M | 18.44M | 18.31M |
|
|
|||||
| Common Stock & APIC | 105.98M | 108.92M | 104.82M | 100.25M | 100.46M |
| Retained Earnings | -124.17M | -126.11M | -124.18M | -118.53M | -118.43M |
| Treasury Stock & Other | 1.24M | 1.28M | 487.30K | 383.30K | 319.90K |
| Total Common Equity | -16.95M | -15.92M | -18.87M | -17.89M | -17.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 8.57M | 8.83M | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 8.57M | 8.83M | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.95M | -15.92M | -18.87M | -17.89M | -17.65M |
| Total Preferred Equity | 8.57M | 8.83M | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.38M | -7.08M | -18.87M | -17.89M | -17.65M |
|
|
|||||